Mode
Text Size
Log in / Sign up

Review suggests automated stool management system may reduce costs and nursing time in ICU fecal incontinenceNew Device Cuts ICU Fecal Incontinence Costs By 90%

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider potential cost and time savings from automated stool management in ICU, but evidence is limited.

This is a narrative review examining the use of the Qoramatic Automated Stool Management (ASM) system compared to traditional absorbent pads and indwelling balloon catheters for managing fecal incontinence in United States intensive care units. The review synthesizes data from four patients' subgroups, with follow-up duration not reported, and does not specify if it is systematic or meta-analytic.

The authors report that the ASM system may reduce per-patient care costs by 80–94.5% (from $242–$1,344 vs. $1,215–$24,615 for traditional methods) and decrease nursing time by 91–96% (from 6–14 vs. 66–348 minutes per day). They also note that leakage and device-related injuries were nearly eliminated, and hospital stays were shortened by up to 30%. However, absolute numbers, p-values, and confidence intervals are not reported for these outcomes, limiting the ability to assess statistical significance or precision.

Key limitations include the small sample size of four patients' subgroups and lack of reported statistical measures, which reduces the robustness of the findings. The review does not address adverse events, funding, or conflicts of interest. In practice, while the authors describe the ASM system as a transformative solution warranting broader adoption, clinicians should interpret these results cautiously due to the observational and limited nature of the evidence.

New Device Cuts ICU Fecal Incontinence Costs By 90%

The messy reality of ICU care

Imagine being in a hospital bed, unable to move, and worried about where your next bathroom break will happen. For many patients in the Intensive Care Unit (ICU), this fear is real. Fecal incontinence—the inability to control bowel movements—affects between 9% and 40% of these patients.

This is not just an embarrassing problem. It causes serious skin damage, painful sores, and dangerous infections. It also costs hospitals millions of dollars every year.

Current treatments are old and often hurt patients. Nurses use thick, bulky pads that soak up waste. These pads are heavy and can cause skin breakdown. Sometimes, doctors use tubes with balloons inside the rectum to hold waste in. These tubes can cause pain and injury.

Patients feel trapped. They cannot move freely. Their skin gets raw from constant moisture. Nurses spend hours changing these heavy pads, which takes them away from other critical tasks.

The surprising shift

For decades, we have relied on containment. We try to catch the mess before it happens. But catching it is not the same as solving the problem.

But here is the twist. A new review of medical data shows a different path. Researchers looked at a new automated system called Qoramatic. This device does not use balloons or thick pads. It uses a gentle suction method to manage waste automatically.

Think of a clogged drain in your kitchen. You can try to stuff it with a rag, or you can use a machine to clear the blockage. The old way is like stuffing the drain. The new way is like using a machine.

The Qoramatic system works like a smart switch. It gently pulls waste away from the patient's skin. It creates a clean space without putting pressure on the body. This is different from balloon tubes, which squeeze the tissue.

It is like using a vacuum cleaner instead of a wet rag. The result is a dry, clean surface that heals faster.

Researchers compared the new device to the old methods in four groups of patients. The results were clear and powerful.

The new system reduced care costs by 80% to 94.5%. That is a massive drop. Nurses spent 91% to 96% less time changing supplies. Patients had almost zero leaks.

This means less time cleaning and more time caring. Patients also had fewer hospital-acquired pressure injuries and infections. Some patients stayed in the hospital for up to 30% less time because they healed faster.

This doesn't mean this treatment is available yet.

What scientists didn't expect

The team expected cost savings. They did not expect the drop in nursing time to be so high. Saving 60 to 300 minutes a day per patient is huge for a busy ICU.

They also expected fewer skin sores. The data confirmed this. When the skin stays dry, it does not break down. This protects the patient from painful wounds and dangerous bacteria like Clostridioides difficile.

If you are a patient or a family member, this news is hopeful but cautious. This technology is currently being studied in hospitals. It is not something you can buy for home use right now.

If you are worried about a loved one in the ICU, talk to their doctor. Ask if they use advanced incontinence management tools. Knowing what tools are available can help you advocate for better care.

The limitations

This study looked at only four groups of patients. While the numbers are impressive, we need to see if this works for thousands of patients. We also need to know if it works in different types of hospitals.

Early research is always exciting, but it is not the final word. We must be careful not to assume it will work perfectly for everyone immediately.

The future looks bright for ICU care. If more hospitals adopt this system, patient outcomes will improve. Costs will go down. Nurses will have more time to help patients who need it most.

More trials will likely follow to prove safety and effectiveness on a larger scale. Until then, this research gives us a clear goal: better, cleaner, and safer care for everyone in the hospital.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
Fecal incontinence (FI) poses a significant clinical and economic challenge in the U.S. intensive care units (ICUs), affecting 9–40% of patients and contributing to billions of dollars in healthcare costs mainly towards complications such as incontinence-associated dermatitis (IAD), hospital-acquired pressure injuries (HAPI), and Clostridioides difficile infection (CDI). This review traces the evolution of FI management from rudimentary containment methods to the newest innovative Qoramatic Automated Stool Management (ASM) system with no balloon and zero radial pressure. We compared Qoramatic ASM to traditional absorbent pads and indwelling balloon catheters (IBCs) across four patients’ subgroups Results demonstrate that Qoramatic ASM reduces per-patient care costs by 80–94.5% ($242–$1,344 vs. $1,215–$24,615 for pads/IBCs), decreases nursing time 91–96% (6–14 vs. 66–348 min/day), and nearly eliminates leakage and device-related injuries. ASM also reduces HAPI and CDI incidence, shortening hospital stays by up to 30%. Qoramatic’s improved clinical outcomes, enhanced patient dignity, and reduced staff burden positioning it is a transformative solution for FI management in ICUs, warranting broader global adoption.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.